Literature DB >> 9506567

Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia.

J H Park1, P Phothimat, C T Oates, M Hernanz-Schulman, N J Olsen.   

Abstract

OBJECTIVE: To investigate the metabolic and functional status of muscles of fibromyalgia (FM) patients, using P-31 magnetic resonance spectroscopy (MRS).
METHODS: Twelve patients with FM and 11 healthy subjects were studied. Clinical status was assessed by questionnaire. Biochemical status of muscle was evaluated with P-31 MRS by determining concentrations of inorganic phosphate (Pi), phosphocreatine (PCr), ATP, and phosphodiesters during rest and exercise. Functional status was evaluated from the PCr/Pi ratio, phosphorylation potential (PP), and total oxidative capacity (Vmax).
RESULTS: Patients with FM reported greater difficulty in performing activities of daily living as well as increased pain, fatigue, and weakness compared with controls. MRS measurements showed that patients had significantly lower than normal PCr and ATP levels (P < 0.004) and PCr/Pi ratios (P < 0.04) in the quadriceps muscles during rest. Values for PP and Vmax also were significantly reduced during rest and exercise.
CONCLUSION: P-31 MRS provides objective evidence for metabolic abnormalities consistent with weakness and fatigue in patients with FM. Noninvasive P-31 MRS may be useful in assessing clinical status and evaluating the effectiveness of treatment regimens in FM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506567     DOI: 10.1002/1529-0131(199803)41:3<406::AID-ART5>3.0.CO;2-L

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

Review 1.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

2.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 3.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

4.  Strength training induced adaptations in neuromuscular function of premenopausal women with fibromyalgia: comparison with healthy women.

Authors:  A Häkkinen; K Häkkinen; P Hannonen; M Alen
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

Review 5.  Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia.

Authors:  J H Park; K J Niermann; N Olsen
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

Review 6.  Pain in patients with fibromyalgia syndrome.

Authors:  D C Turk; A Okifuji
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

Review 7.  Resistance exercise training for fibromyalgia.

Authors:  Angela J Busch; Sandra C Webber; Rachel S Richards; Julia Bidonde; Candice L Schachter; Laurel A Schafer; Adrienne Danyliw; Anuradha Sawant; Vanina Dal Bello-Haas; Tamara Rader; Tom J Overend
Journal:  Cochrane Database Syst Rev       Date:  2013-12-20

Review 8.  Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia.

Authors:  Roland Staud
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

9.  Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres.

Authors:  H Sprott; S Salemi; R E Gay; L A Bradley; G S Alarcón; S J Oh; B A Michel; S Gay
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

Review 10.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.